Product Information
Registration Status: ActiveSIN14149P
DYNASTAT POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 40MG is approved to be sold in Singapore with effective from 2012-05-14. It is marketed by PFIZER PTE LTD, with the registration number of SIN14149P.
This product contains Parecoxib 40mg in the form of INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. It is approved for INTRAVENOUS, INTRAMUSCULAR use.
This product is manufactured by Pharmacia & Upjohn Company LLC (Powder) in UNITED STATES,Actavis Italy S.p.A (Solvent) in ITALY, andPfizer Manufacturing Belgium NV (Solvent) in BELGIUM.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. In 2005, the U.S. Food and Drug Administration (FDA) issued a letter of non-approval for parecoxib in the United States.
Indication
Used for short term perioperative pain control.
Active Ingredient/Synonyms
Parecoxib | Parecoxib |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.